✦ LIBER ✦

Specific active lung cancer immunotherapy: Immune correlates of clinical responses and an update of immunotherapy trials evaluations

Book ID: 122682718
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 165 KB
Volume: 5
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(89)90481-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Specific active lung cancer immunotherap

Specific active lung cancer immunotherapy immune correlates of clinical responses and an update of immunotherapy trials evaluations

✍ Ariel Hollinshead; Hiroshi Takita; Thomas Stewart; Sankaranarayanan Raman 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 836 KB

P11. Developing an immunotherapy strateg

P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials

✍ Neuberger, M; Paustian, C; Hilton, T; Engel, N; Reu, S; Linder, A; Huber, R; Hat 📂 Article 📅 2014 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 80 KB

Adjuvant active specific immunotherapy o

Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise

✍ Michael G. Hanna Jr.; Herbert C. Hoover Jr.; Jan B. Vermorken; Jules E. Harris; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 559 KB

A novel Salmonella Typhi-based immunothe

A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer

✍ Alejandrina Vendrell; María J. Gravisaco; Marcela F. Pasetti; Máximo Croci; Luca 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 571 KB

Epitope-specific immunotherapy of rheuma

Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial

✍ Eva C. Koffeman; Mark Genovese; Diane Amox; Elissa Keogh; Ernesto Santana; Eric 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

786 A randomized, double blind, placebo

786 A randomized, double blind, placebo controlled phase II trial to evaluate the safety and efficacy of recMAGE-A3 + AS15 antigen specific cancer immunotherapy in patients with MAGE-A3 positive muscle invasive bladder cancer after cystectomy: An initial report of the EAU Research Foundation randomized phase II clinical trial ‘Magnolia’

✍ Mulders, P.F.A.; Colombel, M.; Heidenreich, A.; Martínez-Piñeiro, L.; Babjuk, M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 113 KB